Luke Alan Lennox, MD in Concord, NC - Medicare Dermatology

Luke Alan Lennox, MD is a medicare enrolled "Dermatology" physician in Concord, North Carolina. He went to State University Of New York At Buffalo School Of Medicine and graduated in 2014 and has 10 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Lenahan Dermatology Pllc and his current practice location is 200 Medical Park Dr, Ste 460, Concord, North Carolina. You can reach out to his office (for appointments etc.) via phone at (704) 403-2777.

Luke Alan Lennox is licensed to practice in North Carolina (license number 2020-04467) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1912324393.

Contact Information

	Luke Alan Lennox, MD
	200 Medical Park Dr, Ste 460, Concord, NC 28025-2982
	(704) 403-2777
	Not Available

Physician's Profile

Full Name	Luke Alan Lennox
Gender	Male
Speciality	Dermatology
Experience	10 Years
Location	200 Medical Park Dr, Concord, North Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Luke Alan Lennox attended and graduated from State University Of New York At Buffalo School Of Medicine in 2014

NPI Data:

NPI Number: 1912324393
Provider Enumeration Date: 03/24/2014
Last Update Date: 02/28/2023

Medicare PECOS Information:

PECOS PAC ID: 8527354513
Enrollment ID: I20190715000722

Medical Identifiers

Medical identifiers for Luke Alan Lennox such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912324393	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	2020-04467 (North Carolina)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Lenahan Dermatology Pllc	0143574608	6

News Archive

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit presented findings showing that adding curcumin or resveratrol to conventional chemotherapy could be effective in preventing the growth of chemo-resistant colon cancer cells.

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Array BioPharma Inc. (Nasdaq: ARRY) today announced it had entered into an Equity Distribution Agreement with Piper Jaffray & Co. The Equity Distribution Agreement provides that the Company may offer and sell shares of its common stock, par value $0.001 per share, having an aggregate offering price of up to $25,000,000 from time to time through Piper Jaffray, as sales agent.

Preventive dental visits for kids linked to more expensive restorative procedures

It may seem logical that taking children to the dentist for regular preventive check-ups will lead to fewer pricy restorative procedures like filling a cavity. But new findings from the University of Alabama at Birmingham (UAB) published online in Pediatrics show the opposite.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Luke Alan Lennox allows following entities to bill medicare on his behalf.

Entity Name	Buffalo Medical Group, P.c.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1881659506 PECOS PAC ID: 7012820301 Enrollment ID: O20031112000213

News Archive

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Entity Name	Lenahan Dermatology Pllc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1871087221 PECOS PAC ID: 0143574608 Enrollment ID: O20181120000241

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Luke Alan Lennox is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Luke Alan Lennox, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () -	Luke Alan Lennox, MD 200 Medical Park Dr, Ste 460, Concord, NC 28025-2982 Ph: (704) 403-2777

News Archive

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Dermatology Doctors in Concord, NC

Brian Scott Walther, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413
Mr. Aaron Sidscott Wever, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413
Ada Tolutope Ogunsiakan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Park Dr, Ste 460, Concord, NC 28025 Phone: 704-403-2777
Maryanna C Ter Poorten, MD Dermatology Medicare: Medicare Enrolled Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413
Joseph J Roche, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413
Dr. Nathaniel Allen Slater, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901
Dr. Dhwani S Mehta, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413

Luke Alan Lennox, MD - Medicare Dermatology in Concord, NC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Medicare Reassignments

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Curcumin or resveratrol added to conventional chemotherapy decreases survival of colon cancer cells

Array Biopharma and Piper Jaffray enter into Equity Distribution Agreement

Preventive dental visits for kids linked to more expensive restorative procedures

Dermatology Doctors in Concord, NC